HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniel Weisdorf Selected Research
Daniel Weisdorf Research Topics
Disease
28
Graft vs Host Disease (Graft-Versus-Host Disease)
10/2022 - 11/2002
27
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 10/2007
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2022 - 01/2002
16
Leukemia
09/2021 - 02/2006
15
Neoplasms (Cancer)
10/2022 - 03/2004
13
Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 07/2007
11
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2021 - 10/2007
10
Bronchiolitis Obliterans Syndrome
10/2022 - 11/2005
7
Multiple Myeloma
12/2020 - 03/2004
6
Infections
10/2022 - 01/2003
6
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 03/2004
5
Residual Neoplasm
07/2017 - 11/2005
4
Chromosome Aberrations (Chromosome Abnormalities)
10/2022 - 01/2020
3
Stomatitis
01/2021 - 06/2004
3
Lymphoma (Lymphomas)
01/2021 - 09/2006
3
COVID-19
01/2021 - 01/2020
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2020 - 04/2012
3
Pathologic Complete Response
01/2020 - 09/2013
2
Neutropenia
01/2021 - 10/2015
2
Systemic Mastocytosis
01/2016 - 10/2014
1
Hyperammonemia
01/2022
1
Brain Diseases (Brain Disorder)
01/2022
1
Calculi (Calculus)
01/2021
1
Frailty
01/2021
1
Viremia
01/2021
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1
monosomy Chromosome 7
01/2020
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2020
1
Hodgkin Disease (Hodgkin's Disease)
01/2019
1
Cardiotoxicity
01/2017
1
Myeloid Leukemia (Leukemia, Myelocytic)
06/2012
1
Communicable Diseases (Infectious Diseases)
03/2012
1
Overweight
12/2011
1
Disease Progression
12/2011
1
Obesity
12/2011
1
Chromosomal Instability (Chromosome Stability)
09/2011
1
Aneuploidy (Aneuploid)
09/2011
1
Hypertension (High Blood Pressure)
02/2007
1
Nausea
09/2006
1
Hypotension (Low Blood Pressure)
09/2006
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
07/2006
Drug/Important Bio-Agent (IBA)
6
Steroids
IBA
10/2022 - 10/2004
5
fludarabine
IBA
01/2022 - 11/2010
5
Mycophenolic Acid (Cellcept)
FDA Link
Generic
01/2019 - 12/2005
4
Core Binding Factors (Core-Binding Factor)
IBA
01/2021 - 12/2014
4
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2021 - 03/2004
4
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2020 - 11/2010
3
Melphalan (Alkeran)
FDA Link
Generic
11/2021 - 12/2011
3
Busulfan (Busulfex)
FDA Link
11/2021 - 01/2018
3
Antilymphocyte Serum (Anti-Thymocyte Globulin)
IBA
01/2020 - 10/2012
3
Tyrosine Kinase Inhibitors
IBA
01/2020 - 04/2012
3
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2019 - 08/2005
3
Ligands
IBA
09/2015 - 08/2006
3
Rituximab (Mabthera)
FDA Link
10/2012 - 10/2007
2
Fibroblast Growth Factor 7
FDA Link
01/2021 - 12/2004
2
KIR Receptors
IBA
01/2019 - 08/2006
2
Cytarabine (Cytosar-U)
FDA Link
Generic
10/2018 - 06/2013
2
Interleukin-15 (Interleukin 15)
IBA
04/2018 - 01/2018
2
Sorafenib (BAY 43-9006)
FDA Link
04/2018 - 01/2018
2
trans-crotonin (CTN)
IBA
01/2017 - 12/2011
2
plerixafor
FDA Link
02/2009 - 03/2004
2
ProMune (CpG 7909)
IBA
10/2007 - 09/2006
2
HLA-A Antigens (HLA-A)
IBA
08/2006 - 10/2004
1
Chimeric Antigen Receptors
IBA
01/2022
1
Filgrastim (Neupogen)
FDA Link
01/2021
1
Foscarnet
FDA Link
Generic
01/2021
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2021
1
Biosimilar Pharmaceuticals
IBA
01/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2020
1
Alemtuzumab (Campath)
FDA Link
01/2020
1
Immunoglobulins (Immunoglobulin)
IBA
01/2019
1
Clofarabine (Clolar)
FDA Link
10/2018
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2018
1
HLA Antigens (Human Leukocyte Antigens)
IBA
09/2017
1
Nerve Growth Factor (NGF)
IBA
10/2015
1
Lenalidomide (CC 5013)
FDA Link
08/2014
1
Biological Products
IBA
12/2011
1
Interleukin-2 (IL2)
IBA
11/2010
1
Fluorescein (Funduscein)
FDA Link
Generic
09/2010
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
03/2010
1
Toll-Like Receptor 9
IBA
10/2007
1
Immunosuppressive Agents (Immunosuppressants)
IBA
02/2007
1
Oligodeoxyribonucleotides
IBA
09/2006
1
CPG-oligonucleotide
IBA
09/2006
1
HLA-B Antigens (HLA-B)
IBA
08/2006
Therapy/Procedure
45
Cell Transplantation
10/2022 - 12/2005
33
Transplantation
10/2022 - 01/2002
31
Therapeutics
01/2022 - 06/2004
25
Hematopoietic Stem Cell Transplantation
01/2022 - 12/2004
11
Drug Therapy (Chemotherapy)
09/2021 - 06/2004
7
Homologous Transplantation
11/2021 - 11/2012
7
Stem Cell Transplantation
12/2011 - 06/2006
6
Bone Marrow Transplantation (Transplantation, Bone Marrow)
09/2014 - 11/2002
1
Patient Readmission
01/2021
1
Induction Chemotherapy
01/2020
1
Length of Stay
01/2019
1
Haploidentical Transplantation
06/2012
1
Autologous Transplantation
12/2011
1
Catheters
09/2006
1
Intravenous Infusions
09/2006